YBTI(SH:600883)2025-10-30 09:15Financial Performance - Operating revenue for Q3 2025 reached ¥5,433,333.05, an increase of 43.04% year-on-year, while year-to-date revenue was ¥34,123,025.72, up 66.46% compared to the same period last year[2] - Total profit for Q3 2025 was ¥7,813,487.59, a decrease of 57.41% year-on-year, and year-to-date profit totaled ¥21,796,727.94, down 62.10%[2] - Net profit attributable to shareholders for Q3 2025 was ¥7,899,722.42, down 57.71% year-on-year, with year-to-date net profit at ¥22,251,103.99, a decline of 61.91%[2] - The basic earnings per share for Q3 2025 was ¥0.0335, a decrease of 57.65% year-on-year, while year-to-date earnings per share was ¥0.0942, down 61.94%[2] - The net profit for the first three quarters of 2025 is CNY 21,796,727.94, a decrease of 62.1% compared to CNY 57,509,100.78 in the same period of 2024[22] - The total comprehensive income for the first three quarters of 2025 is CNY 18,729,667.50, down from CNY 62,310,258.75 in 2024, reflecting a decline of 69.9%[24] - Basic and diluted earnings per share for the first three quarters of 2025 are CNY 0.0942, compared to CNY 0.2475 in 2024, representing a decrease of 61.9%[24] Cash Flow and Investments - The net cash flow from operating activities was reported as not applicable, with a year-to-date figure of -¥16,649,824.22[2] - Cash inflow from operating activities for the first three quarters of 2025 is CNY 53,108,253.14, significantly higher than CNY 23,959,469.70 in 2024, marking an increase of 121.1%[24] - The net cash flow from investing activities for the first three quarters of 2025 is CNY 151,440,770.03, a substantial improvement from a net outflow of CNY 22,261,991.81 in 2024[26] - The net cash flow from financing activities for the first three quarters of 2025 is CNY -11,650,854.86, compared to CNY -10,833,956.44 in 2024, indicating a slight increase in cash outflow[26] - The cash and cash equivalents at the end of the third quarter of 2025 amount to CNY 157,986,129.98, a significant increase from CNY 35,770,381.68 at the end of 2024[26] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥1,046,472,247.72, an increase of 0.72% from the end of the previous year[2] - Total assets as of September 30, 2025, were RMB 1,046,472,247.72, compared to RMB 1,038,967,341.66 at the end of 2024, marking a slight increase of 0.4%[19] - Total liabilities amounted to RMB 60,682,944.29, up from RMB 59,460,750.85, indicating a rise of approximately 2.1%[17] - The company's equity attributable to shareholders reached RMB 980,827,136.65, compared to RMB 974,090,047.99 at the end of 2024, showing an increase of about 0.8%[19] Revenue and Costs - The increase in operating revenue was attributed to higher sales volumes in the edible fungus and coffee businesses, as well as foreign exchange receipts from last year's exports[6] - Total operating revenue for the first three quarters of 2025 reached RMB 34,123,025.72, a significant increase from RMB 20,499,751.17 in the same period of 2024, representing a growth of approximately 66.5%[20] - Total operating costs for the first three quarters of 2025 were RMB 49,995,607.37, compared to RMB 36,003,748.14 in 2024, indicating an increase of about 38.5%[20] Profitability and Margins - The weighted average return on equity for Q3 2025 decreased by 1.3016 percentage points to 0.8077%, and year-to-date it decreased by 4.0055 percentage points to 2.2585%[2] - The company reported an investment income of CNY 51,381,675.08 for the first three quarters of 2025, down from CNY 61,306,175.67 in 2024, reflecting a decrease of 16.5%[22] - The operating profit for the first three quarters of 2025 is CNY 21,800,049.76, a decline of 62.0% compared to CNY 57,524,461.32 in 2024[22] - The company experienced a foreign exchange loss of CNY 14,180,880.00 in 2025, contrasting with a gain of CNY 11,513,290.00 in 2024[22] Research and Development - Research and development expenses were not explicitly detailed in the report, but management indicated a focus on innovation and technology development moving forward[20]